Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Search Results

19 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Publication Date timeline is not available.
Page 1
Validation of newly derived polygenic risk scores for dementia in a prospective study of older individuals.
Yu C, Ryan J, Orchard SG, Robb C, Woods RL, Wolfe R, Renton AE, Goate AM, Brodtmann A, Shah RC, Chong TT, Sheets K, Kyndt C, Sood A, Storey E, Murray AM, McNeil JJ, Lacaze P. Yu C, et al. Among authors: kyndt c. Alzheimers Dement. 2023 Dec;19(12):5333-5342. doi: 10.1002/alz.13113. Epub 2023 May 12. Alzheimers Dement. 2023. PMID: 37177856 Free PMC article.
A phase 1b open-label study of sodium selenate as a disease-modifying treatment for possible behavioral variant frontotemporal dementia.
Vivash L, Malpas CB, Meletis C, Gollant M, Eratne D, Li QX, McDonald S, O'Brien WT, Brodtmann A, Darby D, Kyndt C, Walterfang M, Hovens CM, Velakoulis D, O'Brien TJ. Vivash L, et al. Among authors: kyndt c. Alzheimers Dement (N Y). 2022 May 5;8(1):e12299. doi: 10.1002/trc2.12299. eCollection 2022. Alzheimers Dement (N Y). 2022. PMID: 35574563 Free PMC article.
Peripheral Immune Cell Ratios and Clinical Outcomes in Seropositive Autoimmune Encephalitis: A Study by the Australian Autoimmune Encephalitis Consortium.
Broadley J, Wesselingh R, Seneviratne U, Kyndt C, Beech P, Buzzard K, Nesbitt C, D'Souza W, Brodtmann A, Kalincik T, Butzkueven H, O'Brien TJ, Monif M; Australian Autoimmune Encephalitis Consortium. Broadley J, et al. Among authors: kyndt c. Front Immunol. 2021 Jan 14;11:597858. doi: 10.3389/fimmu.2020.597858. eCollection 2020. Front Immunol. 2021. PMID: 33519810 Free PMC article.
Psychometric deficits in autoimmune encephalitis: A retrospective study from the Australian Autoimmune Encephalitis Consortium.
Griffith S, Wesselingh R, Broadley J, O'Shea M, Kyndt C, Meade C, Long B, Seneviratne U, Reidy N, Bourke R, Buzzard K, D'Souza W, Macdonell R, Brodtmann A, Butzkueven H, O'Brien TJ, Alpitsis R, Malpas CB, Monif M; Australian Autoimmune Encephalitis Consortium. Griffith S, et al. Among authors: kyndt c. Eur J Neurol. 2022 Aug;29(8):2355-2366. doi: 10.1111/ene.15367. Epub 2022 May 20. Eur J Neurol. 2022. PMID: 35460305
Prognostic value of acute cerebrospinal fluid abnormalities in antibody-positive autoimmune encephalitis.
Broadley J, Wesselingh R, Seneviratne U, Kyndt C, Beech P, Buzzard K, Nesbitt C, D'souza W, Brodtmann A, Macdonell R, Kalincik T, Butzkueven H, O'Brien TJ, Monif M; Australian Autoimmune Encephalitis Consortium. Broadley J, et al. Among authors: kyndt c. J Neuroimmunol. 2021 Apr 15;353:577508. doi: 10.1016/j.jneuroim.2021.577508. Epub 2021 Jan 30. J Neuroimmunol. 2021. PMID: 33588218
Neuroimaging characteristics may aid in diagnosis, subtyping, and prognosis in autoimmune encephalitis.
Broadley J, Wesselingh R, Beech P, Seneviratne U, Kyndt C, Buzzard K, Nesbitt C, D'Souza W, Brodtmann A, Macdonell R, Kalincik T, O'Brien TJ, Butzkueven H, Monif M; Australian Autoimmune Encephalitis Consortium. Broadley J, et al. Among authors: kyndt c. Neurol Sci. 2023 Apr;44(4):1327-1340. doi: 10.1007/s10072-022-06523-9. Epub 2022 Dec 8. Neurol Sci. 2023. PMID: 36481972
Safety and Efficacy of Semorinemab in Individuals With Prodromal to Mild Alzheimer Disease: A Randomized Clinical Trial.
Teng E, Manser PT, Pickthorn K, Brunstein F, Blendstrup M, Sanabria Bohorquez S, Wildsmith KR, Toth B, Dolton M, Ramakrishnan V, Bobbala A, Sikkes SAM, Ward M, Fuji RN, Kerchner GA; Tauriel Investigators. Teng E, et al. JAMA Neurol. 2022 Aug 1;79(8):758-767. doi: 10.1001/jamaneurol.2022.1375. JAMA Neurol. 2022. PMID: 35696185 Free PMC article. Clinical Trial.
Thrombolysis Guided by Perfusion Imaging up to 9 Hours after Onset of Stroke.
Ma H, Campbell BCV, Parsons MW, Churilov L, Levi CR, Hsu C, Kleinig TJ, Wijeratne T, Curtze S, Dewey HM, Miteff F, Tsai CH, Lee JT, Phan TG, Mahant N, Sun MC, Krause M, Sturm J, Grimley R, Chen CH, Hu CJ, Wong AA, Field D, Sun Y, Barber PA, Sabet A, Jannes J, Jeng JS, Clissold B, Markus R, Lin CH, Lien LM, Bladin CF, Christensen S, Yassi N, Sharma G, Bivard A, Desmond PM, Yan B, Mitchell PJ, Thijs V, Carey L, Meretoja A, Davis SM, Donnan GA; EXTEND Investigators. Ma H, et al. N Engl J Med. 2019 May 9;380(19):1795-1803. doi: 10.1056/NEJMoa1813046. N Engl J Med. 2019. PMID: 31067369 Clinical Trial.
Intravenous alteplase for stroke with unknown time of onset guided by advanced imaging: systematic review and meta-analysis of individual patient data.
Thomalla G, Boutitie F, Ma H, Koga M, Ringleb P, Schwamm LH, Wu O, Bendszus M, Bladin CF, Campbell BCV, Cheng B, Churilov L, Ebinger M, Endres M, Fiebach JB, Fukuda-Doi M, Inoue M, Kleinig TJ, Latour LL, Lemmens R, Levi CR, Leys D, Miwa K, Molina CA, Muir KW, Nighoghossian N, Parsons MW, Pedraza S, Schellinger PD, Schwab S, Simonsen CZ, Song SS, Thijs V, Toni D, Hsu CY, Wahlgren N, Yamamoto H, Yassi N, Yoshimura S, Warach S, Hacke W, Toyoda K, Donnan GA, Davis SM, Gerloff C; Evaluation of unknown Onset Stroke thrombolysis trials (EOS) investigators. Thomalla G, et al. Lancet. 2020 Nov 14;396(10262):1574-1584. doi: 10.1016/S0140-6736(20)32163-2. Epub 2020 Nov 8. Lancet. 2020. PMID: 33176180 Free PMC article.
19 results